Achelrod, D., Welte, T., Schreyögg, J. and Stargardt, T., 2016. Costs and outcomes of the German disease management programme (DMP) for chronic obstructive pulmonary disease (COPD)—A large population-based cohort study. Health Policy, 120(9), pp.1029–1039. 10.1016/j.healthpol.2016.08.002. Aitken, M. and Gorokhovich, L., 2012. Advancing the Responsible Use of Medicines: Applying Levers for Change. SSRN Electronic Journal. [online] 10.2139/ssrn.2222541. Arefian, H., Hagel, S., Fischer, D., Scherag, A., Brunkhorst, F.M., Maschmann, J. and Hartmann, M., 2019. Estimating extra length of stay due to healthcare-associated infections before and after implementation of a hospital-wide infection control program. PLOS ONE, 14(5), p.e0217159. 10.1371/journal.pone.0217159. Arefian, H., Hagel, S., Heublein, S., Rissner, F., Scherag, A., Brunkhorst, F.M., Baldessarini, R.J. and Hartmann, M., 2016. Extra length of stay and costs because of health care–associated infections at a German university hospital. American Journal of Infection Control, 44(2), pp.160–166. 10.1016/j.ajic.2015.09.005. Arrospide, A., Idigoras, I., Mar, J., de Koning, H., van der Meulen, M., Soto-Gordoa, M., Martinez-Llorente, J.M., Portillo, I., Arana-Arri, E., Ibarrondo, O. and Lansdorp-Vogelaar, I., 2018. Cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using MISCAN-Colon microsimulation model. BMC Cancer, [online] 18(1). 10.1186/s12885-018-4362-1. Bender, J.M., Virgallito, M., Newland, J.G., Sammons, J.S., Thorell, E.A., Coffin, S.E., Pavia, A.T., Sandora, T.J. and Hersh, A.L., 2015. Infection Prevention and Control Practices in Children’s Hospitals. Infection Control & Hospital Epidemiology, 36(5), pp.597–600. 10.1017/ice.2015.23. Blanco, I., Diego, I., Bueno, P., Fernandez, E., Casas-Maldonado, F., Esquinas, C., Soriano, J.B. and Miravitlles, M., 2017. Geographical distribution of COPD prevalence in Europe, estimated by an inverse distance weighting interpolation technique. International Journal of Chronic Obstructive Pulmonary Disease, Volume 13, pp.57–67. 10.2147/COPD.S150853. Bourbeau, J., Granados, D., Roze, S., Durand-Zaleski, I., Casan, P., Köhler, D., Tognella, S., Viejo, J.L., Dal Negro, R.W. and Kessler, R., 2019. Cost-effectiveness of the COPD Patient Management European Trial home-based disease management program. International Journal of Chronic Obstructive Pulmonary Disease, Volume 14, pp.645–657. 10.2147/COPD.S173057. Danasekaran, R. et al., 2014. Prevention of heathcare associated infections: protecting patients, saving lives. International Journal of Community Medicine and Public Health, 1(1), pp.67–68. Eisinger, F., Cals, L., Calazel-Benque, A., Blay, J.-Y., Coscas, Y., Dolbeault, S., Namer, M., Pivot, X., Rixe, O., Serin, D., Roussel, C. and Morère, J.-F., 2008. Impact of organised programs on colorectal cancer screening. BMC Cancer, [online] 8(1). 10.1186/1471-2407-8-104. Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J.W.W., Comber, H., Forman, D. and Bray, F., 2013. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. European Journal of Cancer, 49(6), pp.1374–1403. 10.1016/j.ejca.2012.12.027. Gijo, E.V. and Antony, J., 2014. Reducing Patient Waiting Time in Outpatient Department Using Lean Six Sigma Methodology: Lean Six Sigma in Outpatient Department of Hospital. Quality and Reliability Engineering International, 30(8), pp.1481–1491. 10.1002/qre.1552. Hagel, S., Ludewig, K., Pletz, M.W., Frosinski, J., Moeser, A., Wolkewitz, M., Gastmeier, P., Harbarth, S., Brunkhorst, F.M., Kesselmeier, M. and Scherag, A., 2019. Effectiveness of a hospital-wide infection control programme on the incidence of healthcare-associated infections and associated severe sepsis and septic shock: a prospective interventional study. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 25(4), pp.462–468. 10.1016/j.cmi.2018.07.010. Hudson, L.O., Murphy, C.R., Spratt, B.G., Enright, M.C., Elkins, K., Nguyen, C., Terpstra, L., Gombosev, A., Kim, D., Hannah, P., Mikhail, L., Alexander, R., Moore, D.F. and Huang, S.S., 2013. Diversity of Methicillin-Resistant Staphylococcus aureus (MRSA) Strains Isolated from Inpatients of 30 Hospitals in Orange County, California. PLoS ONE, 8(4), p.e62117. 10.1371/journal.pone.0062117. Iannettoni, M.D., Lynch, W.R., Parekh, K.R. and McLaughlin, K.A., 2011. Kaizen Method for Esophagectomy Patients: Improved Quality Control, Outcomes, and Decreased Costs. The Annals of Thoracic Surgery, 91(4), pp.1011–1018. 10.1016/j.athoracsur.2011.01.001. Idigoras, I., Arrospide, A., Portillo, I., Arana-Arri, E., Martínez-Indart, L., Mar, J., de Koning, H.J., Lastra, R., Soto-Gordoa, M., van der Meulen, M. and Lansdorp-Vogelaar, I., 2018. Evaluation of the colorectal cancer screening Programme in the Basque Country (Spain) and its effectiveness based on the Miscan-colon model. BMC Public Health, [online] 18(1). 10.1186/s12889-017-4639-3. Improta, G., Cesarelli, M., Montuori, P., Santillo, L.C. and Triassi, M., 2018. Reducing the risk of healthcare-associated infections through Lean Six Sigma: The case of the medicine areas at the Federico II University Hospital in Naples (Italy). Journal of Evaluation in Clinical Practice, 24(2), pp.338–346. 10.1111/jep.12844. Jensen, H., Tørring, M.L., Olesen, F., Overgaard, J., Fenger-Grøn, M. and Vedsted, P., 2015. Diagnostic intervals before and after implementation of cancer patient pathways – a GP survey and registry based comparison of three cohorts of cancer patients. BMC Cancer, [online] 15(1). 10.1186/s12885-015-1317-7. Jensen, H., Tørring, M.L. and Vedsted, P., 2017. Prognostic consequences of implementing cancer patient pathways in Denmark: a comparative cohort study of symptomatic cancer patients in primary care. BMC Cancer, [online] 17(1). 10.1186/s12885-017-3623-8. Jönsson, B., Hofmarcher, T., Lindgren, P. and Wilking, N., 2016a. Comparator report on patient access to cancer medicines in Europe Revisited. p.228. Jönsson, B., Hofmarcher, T., Lindgren, P. and Wilking, N., 2016b. The cost and burden of cancer in the European Union 1995–2014. European Journal of Cancer, 66, pp.162–170. 10.1016/j.ejca.2016.06.022. Kessler, R., Casan-Clara, P., Koehler, D., Tognella, S., Viejo, J.L., Dal Negro, R.W., Díaz-Lobato, S., Reissig, K., Rodríguez González-Moro, J.M., Devouassoux, G., Chavaillon, J.-M., Botrus, P., Arnal, J.-M., Ancochea, J., Bergeron-Lafaurie, A., De Abajo, C., Randerath, W.J., Bastian, A., Cornelissen, C.G., Nilius, G., Texereau, J.B. and Bourbeau, J., 2018. COMET: a multicomponent home-based disease-management programme versus routine care in severe COPD. European Respiratory Journal, 51(1), p.1701612. 10.1183/13993003.01612-2017. Lejeune, C., Le Gleut, K., Cottet, V., Galimard, C., Durand, G., Dancourt, V. and Faivre, J., 2014. The cost-effectiveness of immunochemical tests for colorectal cancer screening. Digestive and Liver Disease, 46(1), pp.76–81. 10.1016/j.dld.2013.07.018. Levin, T.R., Jamieson, L., Burley, D.A., Reyes, J., Oehrli, M. and Caldwell, C., 2011. Organized Colorectal Cancer Screening in Integrated Health Care Systems. Epidemiologic Reviews, 33(1), pp.101–110. 10.1093/epirev/mxr007. Maher, R.L., Hanlon, J. and Hajjar, E.R., 2014. Clinical consequences of polypharmacy in elderly. Expert Opinion on Drug Safety, 13(1), pp.57–65. 10.1517/14740338.2013.827660. Mair, A., Wilson, M. and Dreischulte, T., 2019. The polypharmacy programme in Scotland: realistic prescribing. Prescriber, 30(8), pp.10–16. 10.1002/psb.1779. Manoukian, S., Stewart, S., Dancer, S., Graves, N., Mason, H., McFarland, A., Robertson, C. and Reilly, J., 2018. Estimating excess length of stay due to healthcare-associated infections: a systematic review and meta-analysis of statistical methodology. Journal of Hospital Infection, 100(2), pp.222–235. 10.1016/j.jhin.2018.06.003. Masnoon, N., Shakib, S., Kalisch-Ellett, L. and Caughey, G.E., 2017. What is polypharmacy? A systematic review of definitions. BMC Geriatrics, [online] 17(1). 10.1186/s12877-017-0621-2. Mason, S.E., Nicolay, C.R. and Darzi, A., 2015. The use of Lean and Six Sigma methodologies in surgery: A systematic review. The Surgeon, 13(2), pp.91–100. 10.1016/j.surge.2014.08.002. McIntosh, J., Alonso, A. and Codina, C., 2016. D4.1 Report on Case Studies. Miles, A., Cockburn, J., Smith, R.A. and Wardle, J., 2004. A perspective from countries using organized screening programs. Cancer, 101(S5), pp.1201–1213. 10.1002/cncr.20505. Montella, E., Di Cicco, M.V., Ferraro, A., Centobelli, P., Raiola, E., Triassi, M. and Improta, G., 2017. The application of Lean Six Sigma methodology to reduce the risk of healthcare-associated infections in surgery departments: Lean Six Sigma application in General Surgery Departments. Journal of Evaluation in Clinical Practice, 23(3), pp.530–539. 10.1111/jep.12662. Moutel, G., Duchange, N., Lièvre, A., Orgerie, M.B., Jullian, O., Sancho-Garnier, H. and Darquy, S., 2019. Low participation in organized colorectal cancer screening in France: underlying ethical issues. European Journal of Cancer Prevention, 28(1), pp.27–32. 10.1097/CEJ.0000000000000417. National Board of Health and Welfare (Socialstyrelsen), 2019a. Om lärande, prioriteringar och ekonomiska aspekter – Effekter av satsningen på standardiserade vårdförlopp i cancervården – Slutrapport del 2 [On learning, priorities and economic aspects – Effects of investment in standardized care programs in cancer care ]. National Board of Health and Welfare (Socialstyrelsen), p.136. National Board of Health and Welfare (Socialstyrelsen), 2019b. Standardiserade vårdförlopp i cancervården - sammanfattning och samlad bedömning [Standardized care processes in cancer care - Summary and overall assessment]. National Board of Health and Welfare (Socialstyrelsen), p.11. National Board of Health and Welfare (Socialstyrelsen), 2019c. Väntetider, patientperspektiv och strävan mot en jämlik cancervård – Effekter av satsningen på standardiserade vårdförlopp i cancervården – Slutrapport del 1 [Waiting times, patient perspective and the pursuit of equal cancer care – Effects of investing in standardized care programs in cancer care]. National Board of Health and Welfare (Socialstyrelsen), p.113. OECD, 2017. Tackling Wasteful Spending on Health - en - OECD. [online] Available at: http://www.oecd.org/health/tackling-wasteful-spending-on-health-9789264266414-en.htm [Accessed 10 Jan. 2019]. OECD, 2018. Health at a Glance: Europe 2018 - State of Health in the EU Cycle - en - OECD. [online] Available at: http://www.oecd.org/health/health-at-a-glance-europe-23056088.htm [Accessed 10 Jan. 2019]. OECD/EU, 2016. Health at a Glance: Europe 2016. Pellat, A., Deyra, J., Coriat, R. and Chaussade, S., 2018. Results of the national organised colorectal cancer screening program with FIT in Paris. Scientific Reports, [online] 8(1). 10.1038/s41598-018-22481-9. Perencevich, E.N., Sands, K.E., Cosgrove, S.E., Guadagnoli, E., Meara, E. and Platt, R., 2003. Health and Economic Impact of Surgical Site Infections Diagnosed after Hospital Discharge. Emerging Infectious Diseases, 9(2), pp.196–203. 10.3201/eid0902.020232. Portillo, I. et al., 2018. Factors related to the participation and detection of lesions in colorectal cancer screening programme-based faecal immunochemical test. European Journal of Public Health, 28(6), pp.1143–1148. 10.1093/eurpub/cky109. Probst, H.B., Hussain, Z.B. and Andersen, O., 2012. Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians—A national Danish project. Health Policy, 105(1), pp.65–70. 10.1016/j.healthpol.2011.11.001. Roberts, R.R., Scott, R.D., Cordell, R., Solomon, S.L., Steele, L., Kampe, L.M., Trick, W.E. and Weinstein, R.A., 2003. The Use of Economic Modeling to Determine the Hospital Costs Associated with Nosocomial Infections. Clinical Infectious Diseases, 36(11), pp.1424–1432. 10.1086/375061. Schönfeld, V., Diercke, M., Gilsdorf, A., Eckmanns, T. and Walter, J., 2018. Evaluation of the statutory surveillance system for invasive MRSA infections in Germany, 2016–2017. BMC Public Health, [online] 18(1). 10.1186/s12889-018-5971-y. Scottish Government Polypharmacy Model of Care Group, 2018. Polypharmacy Guidance, Realistic prescribing. Scottish Government. Seidling, H.M., Send, A.F.J., Bittmann, J., Renner, K., Dewald, B., Lange, D., Bruckner, T. and Haefeli, W.E., 2017. Medication review in German community pharmacies – Post-hoc analysis of documented drug-related problems and subsequent interventions in the ATHINA-project. Research in Social and Administrative Pharmacy, 13(6), pp.1127–1134. 10.1016/j.sapharm.2016.10.016. Senore, C., Inadomi, J., Segnan, N., Bellisario, C. and Hassan, C., 2015. Optimising colorectal cancer screening acceptance: a review. Gut, 64(7), pp.1158–1177. 10.1136/gutjnl-2014-308081. Suhrcke, M., Nugent, R., Stuckler, D. and Rocco, L., 2006. Chronic disease: an economic perspective. London: Oxford Health Alliance. Wastesson, J.W., Morin, L., Tan, E.C.K. and Johnell, K., 2018. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opinion on Drug Safety, 17(12), pp.1185–1196. 10.1080/14740338.2018.1546841. World Health Organisation, 2013. Health care-associated infections FACT SHEET. World Health Organisation, 2019. Health care-associated infections FACT SHEET. World Health Organization ed., 2009. WHO guidelines on hand hygiene in health care: first global patient safety challenge: clean care is safer care. Geneva, Switzerland: World Health Organization, Patient Safety. World Health Organization, 2017. Guide to cancer early diagnosis. Zelko, E., KlemencKetis, Z. and TusekBunc, K., 2016. Medication Adherence in Elderly with Polypharmacy Living at Home: a Systematic Review of Existing Studies. Materia Socio Medica, 28(2), p.129. 10.5455/msm.2016.28.129-132.